title: Cilostazol augments the inhibition of platelet aggregation in clopidogrel low-responders.
authors: K
authors: K
authors: Lee
authors: J-Y
authors: JY
authors: Kim
authors: B-S
authors: BS
authors: Yoo
authors: J
authors: J
authors: Yoon
authors: M K
authors: MK
authors: Hong
authors: M-S
authors: MS
authors: Ahn
authors: H
authors: H
authors: Choe
authors: S-H
authors: SH
authors: Lee
mesh_terms: D001792:Blood Platelets / Q000187:drug effects*; D000077407:Cilostazol; D000077144:Clopidogrel; D004357:Drug Synergism; D054855:Drug-Eluting Stents; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D010979:Platelet Function Tests; D011446:Prospective Studies; D058925:Receptors, Purinergic P2Y12 / Q000378:metabolism; D013777:Tetrazoles / Q000494:pharmacology*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D058925:Receptors, Purinergic P2Y12; D013777:Tetrazoles; D000077144:Clopidogrel; D000077407:Cilostazol; D013988:Ticlopidine